Raymond James & Associates Synlogic, Inc. Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.89 - $2.47 $890 - $2,470	1,000 Added 9.09%	12,000 $14,000
Q3 2021 Nov 02, 2021	BUY	$2.45 - $4.1 $26,950 - $45,099	11,000 New	11,000 $34,000
Q1 2021 May 14, 2021	SELL	$2.2 - $5.05 $36,300 - $83,325	-16,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.85 - $2.54 $30,525 - $41,910	16,500 New	16,500 $36,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.